Korro Bio (KRRO) Accumulated Expenses (2019 - 2025)
Historic Accumulated Expenses for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to $5.9 million.
- Korro Bio's Accumulated Expenses rose 736.4% to $5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year increase of 736.4%. This contributed to the annual value of $6.2 million for FY2024, which is 3957.11% down from last year.
- Korro Bio's Accumulated Expenses amounted to $5.9 million in Q3 2025, which was up 736.4% from $5.7 million recorded in Q2 2025.
- Korro Bio's Accumulated Expenses' 5-year high stood at $10.2 million during Q4 2023, with a 5-year trough of $2.8 million in Q1 2021.
- For the 5-year period, Korro Bio's Accumulated Expenses averaged around $5.4 million, with its median value being $5.5 million (2024).
- Per our database at Business Quant, Korro Bio's Accumulated Expenses tumbled by 4795.94% in 2022 and then soared by 22163.78% in 2023.
- Korro Bio's Accumulated Expenses (Quarter) stood at $6.1 million in 2021, then crashed by 47.96% to $3.2 million in 2022, then soared by 221.64% to $10.2 million in 2023, then plummeted by 39.57% to $6.2 million in 2024, then dropped by 5.02% to $5.9 million in 2025.
- Its last three reported values are $5.9 million in Q3 2025, $5.7 million for Q2 2025, and $3.6 million during Q1 2025.